EML4-ALK translocation in both metachronous second primary lung sarcomatoid carcinoma and lung adenocarcinoma: A case report

Lung Cancer

Volumn 81, Issue 2, 2013, Pages 297-301

  Alì, Greta ^a   Proietti, Agnese ^b   Niccoli, Cristina ^b   Pelliccioni, Serena ^a   Borrelli, Nicla ^b   Giannini, Riccardo ^b   Lupi, Cristiana ^a   Valetto, Angelo ^a   Bertini, Veronica ^a   Lucchi, Marco ^a   Mussi, Alfredo ^b   Fontanini, Gabriella ^b  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Adenocarcinoma; Array comparative genomic hybridization; EML4 ALK rearrangement; Fluorescent in situ hybridization; Immunohistochemistry; Lung; Reverse transcriptase polymerase chain reaction; Sarcomatoid carcinoma

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CRIZOTINIB; CYTOKERATIN; ECHINODERM MICROTUBULE ASSOCIATED PROTEIN LIKE 4; ESTROGEN RECEPTOR; FLUORODEOXYGLUCOSE; MEMBRANE PROTEIN; NAPSIN A; PROGESTERONE RECEPTOR; PROTEIN P63; THYROID TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; ARTICLE; CANCER SURGERY; CASE REPORT; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE REARRANGEMENT; GENE TRANSLOCATION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG ADENOCARCINOMA; LUNG CARCINOMA; LUNG LOBECTOMY; LUNG NODULE; LUNG SARCOMATOID CARCINOMA; LYMPH NODE METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; THORACOTOMY; THORAX RADIOGRAPHY;

ADENOCARCINOMA; ARRAY COMPARATIVE GENOMIC HYBRIDIZATION; EML4-ALK REARRANGEMENT; FLUORESCENT IN SITU HYBRIDIZATION; IMMUNOHISTOCHEMISTRY; LUNG; REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION; SARCOMATOID CARCINOMA;

ADENOCARCINOMA; FEMALE; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; SARCOMA; TRANSLOCATION, GENETIC;

EID: 84879885432     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.03.016     Document Type: Article

References (13)

1. Soda M., Choi Y.L., Enomoto M., Takada S., Yamashita Y., Ishikawa S., et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007, 448:561-566.
2. Solomon B., Varella-Garcia M., Camidge D.R. ALK gene rearrangements: a new therapeutic target in a molecularly defined subset of non-small cell lung cancer. J Thorac Oncol 2009, 4:1450-1454.
3. Shaw A.T., Yeap B.Y., Mino-Kenudson M., Digumarthy S.R., Costa D.B., Heist R.S., et al. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. J Clin Oncol 2009, 27:4247-4253.
4. Shaw A.T., Solomon B. Targeting anaplastic lymphoma kinase in lung cancer. Clin Cancer Res 2011, 17:2081-2086.
5. Kwak E.L., Bang Y.J., Camidge D.R., Shaw A.T., Solomon B., Maki R.G., et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 2010, 363:1693-1703.
6. Travis W.D., Brambilla E., Noguchi M., Nicholson A.G., Geisinger K.R., Yatabe Y., et al. International association for the study of lung cancer/american thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011, 6:244-285.
7. Travis W.D., Brambilla E., Muller-Hermelink H.K., Harris C.C. World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart 2004, IARC Press, Lyon.
8. Cho E.K., Tchinda J., Freeman J.L., Chung Y.J., Cai W.W., Lee C. Array-based comparative genomic hybridization and copy number variation in cancer research. Cytogenet Genome Res 2006, 115:262-272.
9. Takahashi T., Sonobe M., Kobayashi M., Yoshizawa A., Menju T., Nakayama E., et al. Clinicopathologic features of non-small-cell lung cancer with EML4-ALK fusion gene. Ann Surg Oncol 2010, 17:889-897.
10. Paik J.H., Choe G., Kim H., Choe J.Y., Lee H.J., Lee C.T., et al. Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization. J Thorac Oncol 2011, 6:466-472.
11. Bollet M.A., Servant N., Neuvial P., Decraene C., Lebigot I., Meyniel J.P., et al. High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers. J Natl Cancer Inst 2008, 100:48-58.
12. Pelosi G., Gasparini P., Cavazza A., Rossi G., Graziano P., Barbareschi M., et al. Multiparametric molecular characterization of pulmonary sarcomatoid carcinoma reveals a nonrandom amplification of anaplastic lymphoma kinase (ALK) gene. Lung Cancer 2012, 77:507-514.
13. Yoshida A., Tsuta K., Nakamura H., Kohno T., Takahashi F., Asamura H., et al. Comprehensive histologic analysis of ALK-rearranged lung carcinomas. Am J Surg Pathol 2011, 35:1226-1234.